Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Company that’s Bringing Customers to Crypto…Fast, Easy & Secure

(Click image to play video) Crypto is back, and so are the companies that are on the leading edge of facilitating the global shift from fiat currency to cryptocurrency. Recently listed on the TSX Venture Exchange, Banxa Holdings Inc. ( TSX-V.BNXA , Forum ...
Dave Jackson | January 11, 2021 |

Exciting Results from One of Ontario’s Newest Gold Explorers

(Image via Cross River Ventures Corp.) For most of October 2020, gold prices have been stuck around $1,900 / Oz. mainly due to the strength of the US dollar, though analysts now expect the price of gold to jump in the next few weeks and yield a “lasting price upswing&...
Stockhouse Editorial | October 20, 2020 |

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...
Fredrick William | September 2, 2020 |

This Cannabis Co. is Mounting its COVID-Comeback

The COVID-19 coronavirus pandemic has forced a massive shift in businesses across the board and this is especially true for 1933 Industries (TGIF) ( CSE:TGIF , OTCQX: TGIFF , Forum ), who reported that during its Q3 2020 , its revenues were adversely impacted by closures...
Dave Jackson | July 24, 2020 |

Do Jobless Claims Point to Sluggish Recovery and Accelerating Gold?

Jobless claims paint a much grimmer picture than other pieces of economic data. So, the Fed (and other central banks) will remain dovish for years, which should support gold prices. More and more economic reports show the beginning of the economic recovery in the U.S. Fol...
Arkadiusz Sieron | June 23, 2020 |

Arcadia Ropes in $3 Million in GoodHemp Seed Purchase Orders Within 50 Days of Product Launch

Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product. Arcadia Biosciences Inc. (RKDA:NASDAQ) , which employs science-based approac...
Streetwise Reports | January 31, 2020 |

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug

Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. This morning, Hamilton, Bermuda based biopharmaceutical company ...
Streetwise Reports | November 21, 2019 |

Ready for Prime Time: Patriot One Technologies Partners with Tech Giants as Commercialization Begins

This small-cap firm's threat detection products have evolved from a single technology to a multi-sensor threat detection platform. With mass shootings becoming all too commonplace, Patriot One Technologies Inc. (PAT:TSX; PTOTF:OTCQX) has been working to develop a th...
Streetwise Reports | November 14, 2019 |

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...
Streetwise Reports | October 17, 2019 |

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...
Streetwise Reports | September 26, 2019 |
1 2